Anzeige
Meldung des Tages: Goldchance mit Substanz: Warum dieses Projekt Investoren aufhorchen lässt

Laboratory of America Aktie News

Aktie
WKN:  A40C39 ISIN:  US5049221055 US-Symbol:  LH Land:  USA
275,70 $
-2,39 $
-0,86%
233,62 € 15:49:01 Uhr
Depot/Watchlist
Marktkapitalisierung *
18,05 Mrd. €
Streubesitz
1,60%
KGV
15,50
Dividende
2,88 $
Dividendenrendite
1,15%
neu: Nachhaltigkeits-Score
49 %
Index-Zuordnung
S&P 500

Laboratory of America News

18.01.26 - wallstreetONLINE Redaktion
Die nächsten großen Gewinner: Nicht Nvidia: Diese Firmen profitieren laut Goldman von KI
Goldman Sachs sieht die größten KI-​Chancen 2026 nicht bei Chips, sondern bei Firmen, die ihre Produktivität stark steigern können.Künstliche Intelligenz trieb den Aktienmarkt im ...
15.01.26 - PR Newswire
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 PR Newswire
14.01.26 - PR Newswire
Labcorp Declares Quarterly Dividend
Labcorp Declares Quarterly Dividend PR Newswire
13.01.26 - PR Newswire
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk PR Newswire
08.01.26 - PR Newswire
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp PR Newswire
30.12.25 - PR Newswire
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
24.11.25 - PR Newswire
Labcorp Appoints Victor Bulto to Board of Directors
Labcorp Appoints Victor Bulto to Board of Directors PR Newswire
19.11.25 - PR Newswire
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research PR Newswire
28.10.25 - PR Newswire
Labcorp Announces 2025 Third Quarter Results
Labcorp Announces 2025 Third Quarter Results PR Newswire
23.10.25 - PR Newswire
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings
Labcorp to Offer First FDA-​Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings PR Newswire
08.10.25 - PR Newswire
Labcorp Declares Quarterly Dividend
Labcorp Declares Quarterly Dividend PR Newswire
30.09.25 - PR Newswire
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities PR Newswire
25.09.25 - PR Newswire
Labcorp to Announce Third Quarter Financial Results on October 28, 2025
Labcorp to Announce Third Quarter Financial Results on October 28, 2025 PR Newswire
15.09.25 - PR Newswire
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses PR Newswire
27.08.25 - PR Newswire
Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference PR Newswire
18.08.25 - PR Newswire
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
Labcorp Launches First FDA-​Cleared Blood Test for Alzheimer's Disease PR Newswire
30.07.25 - PR Newswire
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
Labcorp Introduces Test Finder, a First-​of-Its-Kind Generative AI Tool to Simplify Lab Test Search PR Newswire
29.07.25 - PR Newswire
Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
Labcorp Achieves IVDR CE-​Marking for PGDx elio™ tissue complete in the EU PR Newswire
24.07.25 - PR Newswire
Labcorp Announces 2025 Second Quarter Results
Labcorp Announces 2025 Second Quarter Results PR Newswire
10.07.25 - PR Newswire
Labcorp Declares Quarterly Dividend
Labcorp Declares Quarterly Dividend PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +9,48%
Technical Trading: Pfund Short im Februar
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »